Barriers and facilitators for systematically registering adverse drug reactions in electronic health records: a qualitative study with Dutch healthcare professionals.

Adverse drug reaction adverse drug reaction registration capability – opportunity - motivation – behavior (COM-B) model hospitals

Journal

Expert opinion on drug safety
ISSN: 1744-764X
Titre abrégé: Expert Opin Drug Saf
Pays: England
ID NLM: 101163027

Informations de publication

Date de publication:
May 2022
Historique:
pubmed: 22 1 2022
medline: 3 5 2022
entrez: 21 1 2022
Statut: ppublish

Résumé

Systematically registering ADRs in electronic health records (EHRs) likely contribute to patient safety as it enables the exchange of drug safety data. Currently, ADRs registrations by healthcare professionals (HCPs) is suboptimal. This study aimed to identify barriers and facilitators perceived by HCPs to register ADRs systematically in EHRs. A qualitative study with individual interviews was conducted among specialist physicians and hospital pharmacists from 10 different Dutch hospitals. A semi-structured interview guide was used to identify experienced barriers and facilitators for systematically registering ADRs. Data was analyzed following thematic analysis. Themes within barriers and facilitators were aligned with the Capability-Opportunity-Motivation-Behavior (COM-B) framework. In total, 16 HCPs were interviewed. Identified barriers were: lack of knowledge to recognize ADRs, time constraints, inadequate IT system, lack of support, stuck in routine, and not recognizing the importance of registering ADRs. Identified facilitators were: enhanced knowledge and awareness of ADRs, functional IT systems, expanding accountability for registration, and motivation toward registering. Barriers and facilitators for registering spanned all aspects of the COM-B model and occurred in individual, social and environmental domains. Addressing these aspects could improve the registration of ADRs and may contribute to patient safety.

Sections du résumé

BACKGROUND BACKGROUND
Systematically registering ADRs in electronic health records (EHRs) likely contribute to patient safety as it enables the exchange of drug safety data. Currently, ADRs registrations by healthcare professionals (HCPs) is suboptimal. This study aimed to identify barriers and facilitators perceived by HCPs to register ADRs systematically in EHRs.
RESEARCH DESIGN AND METHODS METHODS
A qualitative study with individual interviews was conducted among specialist physicians and hospital pharmacists from 10 different Dutch hospitals. A semi-structured interview guide was used to identify experienced barriers and facilitators for systematically registering ADRs. Data was analyzed following thematic analysis. Themes within barriers and facilitators were aligned with the Capability-Opportunity-Motivation-Behavior (COM-B) framework.
RESULTS RESULTS
In total, 16 HCPs were interviewed. Identified barriers were: lack of knowledge to recognize ADRs, time constraints, inadequate IT system, lack of support, stuck in routine, and not recognizing the importance of registering ADRs. Identified facilitators were: enhanced knowledge and awareness of ADRs, functional IT systems, expanding accountability for registration, and motivation toward registering.
CONCLUSIONS CONCLUSIONS
Barriers and facilitators for registering spanned all aspects of the COM-B model and occurred in individual, social and environmental domains. Addressing these aspects could improve the registration of ADRs and may contribute to patient safety.

Identifiants

pubmed: 35060443
doi: 10.1080/14740338.2022.2020756
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

699-706

Auteurs

Isa P A C Geeven (IPAC)

Research Department, Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.

Naomi T Jessurun (NT)

Research Department, Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.
Faculty of Science and Engineering, University of Groningen, Groningen, The Netherlands.

Arthur T M Wasylewicz (ATM)

Pharmacology, Catharina Hospital, Eindhoven, The Netherlands.

Marjolein Drent (M)

Department of Pulmonology, St Antonius Hospital, Interstitial Lung Diseases (ILD) Center of Excellence, Nieuwegein, The Netherlands.
Department of Pharmacology and Toxicology, Faculty of Health and Life Sciences, Maastricht University, Maastricht, The Netherlands.
ild Care Foundation Research Team, Ede, The Netherlands.

Phyllis I Spuls (PI)

Department of Dermatology, Amsterdam University Medical Centers, Amsterdam Public Health and Infection and Immunity, University of Amsterdam, Amsterdam, The Netherlands.

Frank Hoentjen (F)

Department of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands.

Eugène P van Puijenbroek (EP)

Research Department, Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.
Reinier van Arkel Mental health Institution, Department of Geriatric and Hospital Psychiatry, 's-Hertogenbosch, The Netherlands.

Harald E Vonkeman (HE)

Department of Rheumatology and Clinical Immunology, Medisch Spectrum Twente, Enschede, The Netherland.
Department of Psychology, Health and Technology, University of Twente, Enschede, The Netherlands.

Koen P Grootens (KP)

Renier van Arkel Mental Health Insitutute 'S Hertogenbosch, The Netherlands.

Martijn B A van Doorn (MBA)

Department Met Dermatology, ErasmusMC, Rotterdam, The Netherlands.

Bart J F van Den Bemt (BJF)

Department of Pharmacy, Sint Maartenskliniek, Ubbergen, The Netherlands.
Department of Pharmacy, Research Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.

Charlotte L Bekker (CL)

Department of Pharmacy, Research Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH